Your session is about to expire
← Back to Search
Cell Therapy
ERIPTO Protocol for Knee Arthritis (ERIPTO Trial)
N/A
Waitlist Available
Led By Mohammed M Qureshi, DO, CAQSM, MRO
Research Sponsored by Affinity Health Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group
Summary
This trial is comparing two different treatments for post-traumatic osteoarthritis of the knee, one involving a bone marrow aspirate concentrate (BMAC) and one involving the ERIPTO protocol. The investigators will be looking at various factors such as time frame from initial injury, type of injury, gender, and age when injury first occurred to see if there is a correlation with the severity of osteoarthritis.
Eligible Conditions
- Knee Arthritis
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Radiographic Changes
Secondary study objectives
Subjective Knee Symptom Changes
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: ERIPTO ProtocolExperimental Treatment1 Intervention
Protocol arm actively being studied
Group II: BMAC onlyActive Control1 Intervention
bone marrow aspirate concentrate only arm
Find a Location
Who is running the clinical trial?
Affinity Health Research InstituteLead Sponsor
The Center for Primary Care and Sports MedicineUNKNOWN
Genesis Orthopedics and Sports MedicineUNKNOWN
Share this study with friends
Copy Link
Messenger